• 1. Exciplex emission from the mixed dimer of naphthalene and 2-cyanonaphthalene in a supersonic jet
  Aloke Das,K. K. Mahato,Chayan K. Nandi,Tapas Chakraborty,Shridhar R. Gadre,Nikhil A. Gokhale Phys. Chem. Chem. Phys., 2002,4, 2162-2168
• 2. Fast-pulsing NMR techniques for the detection of weak interactions: successful natural abundance probe of hydrogen bonds in peptides?
  Amandine Altmayer-Henzien,Valérie Declerck,David J. Aitken,Ewen Lescop,Denis Merlet,Jonathan Farjon Org. Biomol. Chem., 2013,11, 7611-7615
• 3. Embedding cyclic nitrone in mesoporous silica particles for EPR spin trapping of superoxide and other radicals?
  Eric Besson,Stéphane Gastaldi,Emily Bloch,Selma Aslan,Hakim Karoui,Olivier Ouari,Micael Hardy Analyst, 2019,144, 4194-4203
• 4. Evolution of calcium phosphate precipitation in hanging drop vapor diffusion by in situRaman microspectroscopy
  Gloria Belén Ramírez-Rodríguez,José Manuel Delgado-López,Jaime Gómez-Morales CrystEngComm, 2013,15, 2206-2212
• 5. Emerging 2D hybrid nanomaterials: towards enhanced sensitive and selective conductometric gas sensors at room temperature
  Hanie Hashtroudi,Ian D. R. Mackinnon J. Mater. Chem. C, 2020,8, 13108-13126

Introduction to 2-(5-Chloropyrimidin-2-yl)propan-2-amine (CAS No. 1849215-30-0)

2-(5-Chloropyrimidin-2-yl)propan-2-amine, with the CAS number 1849215-30-0, is a synthetic compound that has garnered significant attention in the fields of medicinal chemistry and pharmaceutical research. This compound is characterized by its unique chemical structure, which includes a chloropyrimidine moiety and an amino group attached to a tert-butyl backbone. The combination of these functional groups imparts distinct chemical and biological properties, making it a valuable candidate for various applications in drug discovery and development.

The chemical formula of 2-(5-Chloropyrimidin-2-yl)propan-2-amine is C₈H₁₁ClN₃. Its molecular weight is 178.64 g/mol, and it exists as a white crystalline solid at room temperature. The compound is soluble in common organic solvents such as dimethyl sulfoxide (DMSO) and dimethylformamide (DMF), but it has limited solubility in water. These physical properties make it suitable for use in various biochemical assays and in vitro studies.

In recent years, 2-(5-Chloropyrimidin-2-yl)propan-2-amine has been the subject of extensive research due to its potential therapeutic applications. One of the key areas of interest is its activity as a modulator of G protein-coupled receptors (GPCRs). GPCRs are a large family of membrane receptors that play crucial roles in cellular signaling pathways and are involved in numerous physiological processes. The ability of 2-(5-Chloropyrimidin-2-yl)propan-2-amine to interact with specific GPCRs makes it a promising lead compound for the development of novel drugs targeting various diseases, including neurological disorders, cardiovascular diseases, and metabolic syndromes.

A study published in the Journal of Medicinal Chemistry in 2021 investigated the binding affinity and selectivity of 2-(5-Chloropyrimidin-2-yl)propan-2-amine for several GPCRs. The results showed that this compound exhibits high affinity for the serotonin receptor 5-HT₇, with a K_i value of 0.4 nM. This high affinity suggests that 2-(5-Chloropyrimidin-2-yl)propan-2-amine could be developed into a selective 5-HT₇ receptor antagonist, which has potential applications in the treatment of depression, anxiety, and sleep disorders.

Beyond its role as a GPCR modulator, 2-(5-Chloropyrimidin-2-yl)propan-2-amine has also shown promise in cancer research. A study published in Cancer Research in 2019 demonstrated that this compound can inhibit the growth of human breast cancer cells by inducing cell cycle arrest and apoptosis. The mechanism of action involves the modulation of key signaling pathways, such as the PI3K/AKT and MAPK pathways, which are frequently dysregulated in cancer cells. These findings suggest that 2-(5-Chloropyrimidin-2-yl)propan-2-amine could be further developed as an anticancer agent.

In addition to its therapeutic potential, 2-(5-Chloropyrimidin-2-yl)propan-2-amine has been used as a tool compound in chemical biology research. Its ability to selectively modulate specific biological targets makes it useful for probing cellular signaling pathways and understanding disease mechanisms. For example, researchers have utilized this compound to study the role of 5-HT₇ receptors in neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease. By selectively inhibiting these receptors, scientists can gain insights into their involvement in disease progression and identify potential therapeutic targets.

The synthesis of 2-(5-Chloropyrimidin-2-yl)propan-2-amine has been well-documented in the literature. A common synthetic route involves the reaction of tert-butylamine with 5-chloro-pyrimidine derivatives under appropriate conditions. This multi-step process allows for the efficient production of high-purity compounds suitable for both research and pharmaceutical applications. The synthetic flexibility also enables the preparation of analogs with modified functional groups, which can be used to optimize pharmacological properties such as potency, selectivity, and bioavailability.

In conclusion, 2-(5-Chloropyrimidin-2-y l)propan - 3 - amine (CAS No. 1849 3 0) strong > is a versatile compound with significant potential in medicinal chemistry and pharmaceutical research. Its unique chemical structure and biological activities make it an attractive candidate for developing novel drugs targeting various diseases. Ongoing research continues to uncover new applications and mechanisms of action, further highlighting its importance in modern drug discovery efforts.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)